The impact of primary packaging on the quality of parenteral products

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 3, 2008, Pages 744-748

  Solomun, Ljiljana ^a   Ibric, Svetlana ^b   Boltic, Zorana ^a   Djuric, Zorica ^b   Stupar, Biljana ^a  

^a Hemofarm AD Vrsac ^*  (Serbia)

^b Faculty of Pharmacy   (Serbia)

Author keywords

Dual chamber vials; Injection; Methylprednisolone sodium succinate; Rubber closures formulation

Indexed keywords

BROMOBUTYL DERIVATIVE; CHLOROBUTYL DERIVATIVE; GLASS; METHYLPREDNISOLONE SODIUM SUCCINATE; PARENTERAL SOLUTION; RUBBER; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONTAINER; CONTAINER CLOSURE SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG PACKAGING; DRUG QUALITY; DRUG STABILITY; DUAL CHAMBER VIAL; EQUIPMENT; FREEZE DRYING; MATERIALS TESTING; NONHUMAN; PARENTERAL DRUG ADMINISTRATION; PH MEASUREMENT; PRIORITY JOURNAL; QUALITY CONTROL; SHELF LIFE;

CHEMISTRY, PHARMACEUTICAL; DRUG PACKAGING; DRUG STABILITY; GLASS; HYDROGEN-ION CONCENTRATION; INFUSIONS, PARENTERAL; PHARMACEUTICAL PREPARATIONS; RUBBER; TECHNOLOGY, PHARMACEUTICAL;

EID: 53149097701     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.07.025     Document Type: Article

References (13)

1. Note for guidance on Pharmaceutical Development; The European Medicinal Agency, May, 2006.
2. Thomson MICROMEDEX, Health Series, vol. 134, 2007.
3. European Pharmacopoeia, 6th ed., Strasbourg, France, 2007.
4. US Pharmacopoeia, NF-25. 30th ed. (2007), US Pharmacopoeial Convention, Rockville, MD
5. Guidance for Industry Q1A Stability Testing of New Drug Substances and Products, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001.
6. FDA Guidance for Industry ANDAs, Impurities in Drug Products, 2005.
7. ICH Q1A (R2), Stability Testing of New Drug Substances and Products, ICH Steering Committee, February, 2003.
8. ICH Q1B, Stability Testing: Photostability Testing of New Drug Substances and Products, ICH Steering Committee, November, 1996.
9. ICH Q3B (R1), Impurities in New Drug Products, The European Medicinal Agency, June, 2006.
10. Guideline on Stability Testing: Stability Testing of Existing Active Substances and Related Finished Products, The European Medicinal Agency, March, 2004.
11. Note for Guidance on In-use Stability Testing of Human Medicinal Products, The European Medicinal Agency, September, 2001.
12. Note for Guidance on Maximum Shelf-life for Sterile Products for Human Use after First Opening or Following Reconstitution, The European Medicinal Agency, January, 1998.
13. ICH Q1E Evaluation for Stability Data, ICH Steering Committee, February, 2003.